ATE50913T1 - Impfstoff gegen hundecoronavirus. - Google Patents

Impfstoff gegen hundecoronavirus.

Info

Publication number
ATE50913T1
ATE50913T1 AT84902632T AT84902632T ATE50913T1 AT E50913 T1 ATE50913 T1 AT E50913T1 AT 84902632 T AT84902632 T AT 84902632T AT 84902632 T AT84902632 T AT 84902632T AT E50913 T1 ATE50913 T1 AT E50913T1
Authority
AT
Austria
Prior art keywords
vaccine against
against dog
coronavirus
canine coronavirus
dog coronavirus
Prior art date
Application number
AT84902632T
Other languages
English (en)
Inventor
William M Acree
Bobby Edwards
John W Black
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27054825&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE50913(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US06/504,434 external-priority patent/US4567043A/en
Application filed by American Home Prod filed Critical American Home Prod
Application granted granted Critical
Publication of ATE50913T1 publication Critical patent/ATE50913T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/818—Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
AT84902632T 1983-06-15 1984-06-14 Impfstoff gegen hundecoronavirus. ATE50913T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US06/504,434 US4567043A (en) 1983-06-15 1983-06-15 Canine corona virus vaccine
US06/618,638 US4567042A (en) 1983-06-15 1984-06-07 Inactivated canine coronavirus vaccine
EP84902632A EP0145783B2 (de) 1983-06-15 1984-06-14 Impfstoff gegen hundecoronavirus
PCT/US1984/000904 WO1985000014A1 (en) 1983-06-15 1984-06-14 Canine coronavirus vaccine

Publications (1)

Publication Number Publication Date
ATE50913T1 true ATE50913T1 (de) 1990-03-15

Family

ID=27054825

Family Applications (4)

Application Number Title Priority Date Filing Date
AT89201996T ATE280217T1 (de) 1983-06-15 1984-06-14 Hundecoronavirus
AT84902632T ATE50913T1 (de) 1983-06-15 1984-06-14 Impfstoff gegen hundecoronavirus.
AT89201017T ATE103181T1 (de) 1983-06-15 1989-04-20 Tieraerztliche impfstoffe.
AT89202001T ATE103180T1 (de) 1983-06-15 1989-07-31 Impfstoff-zubereitung.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT89201996T ATE280217T1 (de) 1983-06-15 1984-06-14 Hundecoronavirus

Family Applications After (2)

Application Number Title Priority Date Filing Date
AT89201017T ATE103181T1 (de) 1983-06-15 1989-04-20 Tieraerztliche impfstoffe.
AT89202001T ATE103180T1 (de) 1983-06-15 1989-07-31 Impfstoff-zubereitung.

Country Status (7)

Country Link
US (1) US4567042A (de)
EP (4) EP0329264B1 (de)
AT (4) ATE280217T1 (de)
DE (4) DE3486292T2 (de)
ES (1) ES8604422A1 (de)
NL (1) NL940017I2 (de)
WO (1) WO1985000014A1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4990367A (en) * 1987-03-09 1991-02-05 Diamond Scientific Company Canine distemper virus vaccine
US5565209A (en) * 1987-03-17 1996-10-15 Akzo Nobel N.V. Adjuvant mixture
ES2052685T3 (es) * 1987-03-17 1994-07-16 Akzo Nv Metodo para producir un adyuvante libre.
US4904468A (en) * 1987-06-08 1990-02-27 Norden Laboratories, Inc. Canine coronavirus vaccine
US5911999A (en) * 1987-09-28 1999-06-15 Pfizer, Inc. Vaccine based on TGEV for protection of dogs against canine coronavirus
ZA903142B (en) * 1989-05-03 1991-02-27 Akzo Nv Canine corona virus vaccine
US5672350A (en) * 1989-08-22 1997-09-30 Veterinary Infectious Disease Organization Recombinant bovine coronavirus E2 and E3 polypeptides and vaccines
US6004563A (en) * 1990-11-07 1999-12-21 American Home Products Corporation Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same
US6372224B1 (en) 1990-11-14 2002-04-16 Pfizer Inc. Canine coronavirus S gene and uses therefor
US6057436A (en) * 1990-11-14 2000-05-02 Pfizer Inc. Canine coronavirus S gene and uses therefor
DE69233270T2 (de) * 1991-04-25 2004-09-30 Akzo Nobel N.V. Subeinheits-Impfstoff gegen Hundecoronavirus
US5750112A (en) * 1993-02-26 1998-05-12 Solvay Animal Health, Inc. Canine coronavirus vaccine from feline enteric coronavirus
US20040053208A1 (en) * 1995-08-29 2004-03-18 V. I. TECHNOLOGIES, Inc. Methods to selectively inactivate parasites in biological compositions
US20040048235A1 (en) * 1995-08-29 2004-03-11 V.I. Technologies, Inc. Methods and compositions for the selective modification of nucleic acids
GB9622159D0 (en) * 1996-10-24 1996-12-18 Solvay Sociutu Anonyme Polyanionic polymers as adjuvants for mucosal immunization
US6093564A (en) * 1997-10-03 2000-07-25 V.I. Technologies, Inc. Methods and compositions for the selective modification of nucleic acids
US6369048B1 (en) 1998-01-12 2002-04-09 V.I. Technologies, Inc. Methods and compositions for inactivating viruses
FR2775601B1 (fr) 1998-03-03 2001-09-21 Merial Sas Vaccins vivants recombines et adjuves
US6617100B2 (en) 1998-09-25 2003-09-09 V.I. Technologies, Inc. Solid phase quenching systems
US6150109A (en) 1999-01-25 2000-11-21 V. I. TECHNOLOGIES, Inc. Lipophilic quenching of viral inactivating agents
US20020131958A1 (en) * 2001-01-22 2002-09-19 John Chapman Method for purifying a biological composition
US20030129161A1 (en) * 2001-09-17 2003-07-10 Hsien-Jue Chu Interleukin-12 as a veterinary vaccine adjuvant
EP1575613A1 (de) * 2002-12-19 2005-09-21 Akzo Nobel Trivalenter impfstoff mit maternalem antikörpertransfer über die muttermilch
RU2005124130A (ru) * 2003-01-29 2006-01-20 Пфайзер Продактс Инк. (Us) Вакцины для собак против bordetella bronchiseptica
US20050089533A1 (en) * 2003-01-29 2005-04-28 Joseph Frantz Canine vaccines against Bordetella bronchiseptica
GB0315323D0 (en) * 2003-07-01 2003-08-06 Royal Veterinary College Vaccine composition
US9023366B2 (en) 2003-07-01 2015-05-05 The Royal Veterinary College Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD)
US20060257429A1 (en) * 2003-10-23 2006-11-16 Dreier Kimberly J Vaccine for periodontal disease
CA2604488A1 (en) * 2005-04-07 2006-10-12 Pharmacia & Upjohn Company Llc Formulations and process for production of bordetella bronchiseptica p68 antigen and vaccines
ES2355702T3 (es) * 2005-10-26 2011-03-30 Canio Buonavoglia Coronavirus canino pantrópico.
US7682619B2 (en) * 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
KR101013226B1 (ko) * 2008-05-14 2011-02-10 녹십자수의약품(주) 개 바이러스성 설사병 예방용 백신
US20110110980A1 (en) * 2009-09-02 2011-05-12 Wyeth Llc Heterlogous prime-boost immunization regimen
UY34745A (es) 2012-04-18 2013-11-29 Zoetis Llc Vacunas y procedimientos para tratar la enfermedad de lyme en perros
US20140170180A1 (en) 2012-12-17 2014-06-19 Boehringer Ingelheim Vetmedica, Inc. Porcine parvovirus 5a, methods of use and vaccine
US20140234354A1 (en) 2013-02-15 2014-08-21 Boehringer Ingelheim Vetmedica, Inc. Porcine parvovirus 5b, methods of use and vaccine
US9579373B2 (en) 2013-03-15 2017-02-28 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use
WO2019092027A1 (en) 2017-11-09 2019-05-16 Boehringer Ingelheim Vetmedica Gmbh Sapelovirus immunogenic compositions and uses thereof
BR112021013241A2 (pt) 2019-01-04 2021-09-14 Boehringer Ingelheim Animal Health USA Inc. Cepas atenuadas de bordetella bronchiseptica, vacinas orais contendo as cepas atenuadas e métodos de preparação e uso das mesmas
CN109765384B (zh) * 2019-01-29 2022-11-18 北京勤邦生物技术有限公司 一种犬冠状病毒抗体荧光检测试纸条及其制备方法和应用
CN112402599B (zh) * 2019-08-23 2023-06-27 中国农业科学院特产研究所 一种犬用犬瘟热、细小病毒病二联灭活疫苗及其制备方法
CA3194830A1 (en) * 2020-10-08 2022-04-14 Paula WALKER Methods and apparatuses for detecting respiratory infections
JP7869150B2 (ja) * 2021-01-06 2026-06-02 パナソニックハウジングソリューションズ株式会社 排泄物判定方法、排泄物判定装置、及び排泄物判定プログラム

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3143474A (en) * 1962-07-30 1964-08-04 Sterling Drug Inc Preparation of duck-embryo modified infectious canine hepatitis virus vaccine
US3704203A (en) † 1967-08-24 1972-11-28 Diamond Lab Inc Transmissible gastroenteritis vaccines and methods of producing the same
US3652761A (en) * 1969-09-04 1972-03-28 Corning Glass Works Immunochemical composites and antigen or antibody purification therewith
US3959251A (en) * 1970-06-25 1976-05-25 Exploaterings Aktiebolaget T.B.F. Stabilized agar product and method for its stabilization

Also Published As

Publication number Publication date
EP0344872B2 (de) 2002-04-24
EP0345911B1 (de) 2004-10-20
ES538588A0 (es) 1986-02-01
DE3486293T4 (de) 1995-06-14
EP0344872A1 (de) 1989-12-06
EP0329264A3 (en) 1989-12-13
EP0145783B1 (de) 1990-03-14
EP0145783A1 (de) 1985-06-26
EP0329264B1 (de) 1994-03-23
DE3486495D1 (de) 2004-11-25
EP0344872B1 (de) 1994-03-23
ATE103180T1 (de) 1994-04-15
ATE103181T1 (de) 1994-04-15
DE3481582D1 (de) 1990-04-19
US4567042A (en) 1986-01-28
EP0329264A2 (de) 1989-08-23
NL940017I2 (nl) 2001-02-01
DE3486293T3 (de) 2002-11-21
WO1985000014A1 (en) 1985-01-03
DE3486292T2 (de) 1994-06-30
DE3486292D1 (de) 1994-04-28
NL940017I1 (nl) 1994-10-17
EP0345911A1 (de) 1989-12-13
DE3486293T2 (de) 1994-06-30
EP0145783B2 (de) 2004-01-02
EP0145783A4 (de) 1985-10-14
DE3486293D1 (de) 1994-04-28
ATE280217T1 (de) 2004-11-15
ES8604422A1 (es) 1986-02-01

Similar Documents

Publication Publication Date Title
DE3481582D1 (de) Impfstoff gegen hundecoronavirus.
DE3586841D1 (de) Orale impfstoffe.
DE69202790D1 (de) Futter und Futterzusatzmittel mit einer verbesserten Resistenz gegen Krankheiten wie Pseudorabies für Vieh, Geflügel und Fisch.
DE3882599D1 (de) Hundecoronavirus-impfstoff.
MX151438A (es) Mejoras en dispositivo para exterminar insectos
NL192740B (nl) Oxadethiacefalosporinederivaat met antibacteriële werking, alsmede bereidingswijze daarvoor en antibacteriaal preparaat daaruit.
KR830005871A (ko) 광견병 백신의 제조방법
ES2089891T3 (es) Comprimido veterinario especialmente destinado a los gatos.
FI833770A7 (fi) Orgaanisia yhdisteitä ja niiden käyttö lääkkeinä.
AR019785A1 (es) Pestivirus no diseminantes
KR900017611A (ko) 개의 코로나 바이러스 백신
ES2063048T3 (es) Vacuna para proteccion de gatos contra la peritonitis infecciosa felina.
ATE16348T1 (de) Ozon-inaktivierte keime als vakzine.
ES2023962B3 (es) Sistema para convertir residuos en inocuos para el ambiente.
DK233188D0 (da) Pyrrolophenylalkanolaminer, fremgangsmaader til deres fremstilling samt deres anvendelse som ydelsesfremmende midler til dyr
ES263684Y (es) "jaula de pisos perfeccionada, para la cria y recria en avicultura".
IT8621418V0 (it) Dispositivo di ricircolo dell'acqua nei beverini per animali domestici.
SE8100489L (sv) Sett att framstella en lettblastbetong med hog ballasthalt
PL206024A1 (pl) Torf jako pasza w zywieniu zwierzat domowych i drobiu
ES262322Y (es) "dispositivo impulsor de aire para mantener objetos en flotacion".
IT8234850U1 (it) Box da parto per scrofe trasformabile in box per svezzamento suinetti.
ES263765Y (es) "dispositivo para evitar y detener hemorragias odontologicas".
ES1019745U (es) Asa-pinza recogedora de excrementos caninos.
GT198303306A (es) Dihidropiridinas.
IT1217035B (it) Attrezzatura per pilotare apparecchiature computerizzate, quale emulatore di mouse per disabili motori ed altro.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time
UEP Publication of translation of european patent specification

Ref document number: 0145783

Country of ref document: EP